Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Ofloxacin × Clear all

Phase

Phase 4 2 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hearing Loss 1 Ear Neoplasms 1

Interventions

Cyclophosphamide 560 pembrolizumab 434 Paclitaxel 398 Gemcitabine 384 Cisplatin 379 Carboplatin 378 Radiotherapy 339 fludarabine 319 Nivolumab 298 Bevacizumab 247 Docetaxel 242 Irinotecan 219 Magnetic Resonance Spectroscopy 213 Fluorouracil 200 Dexamethasone 200 Specimen Handling 194 Capecitabine 193 Rituximab 182 Cytarabine 181 Oxaliplatin 176 fludarabine phosphate 174 Temozolomide 173 Biopsy 171 Ipilimumab 166 Lenalidomide 162 Etoposide 162 Doxorubicin 153 Leucovorin 151 Cetuximab 151 Bortezomib 149

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡